In vitro Anti-angiogenic Effects of Tea Saponin and Tea Aglucone on Human Umbilical Vein Endothelial Cells

Xiaohong Li^{1, 2}, Baozhan Huang¹, Fan Fei^{1, 2}, Hai Niu^{1, 3,} and Wen Huang^1,

¹Laboratory of Ethnopharmacology, Regenerative Medicine Research Center, Institute for Nanobiomedical Technology and Membrane Biology, West China Hospital/West China Medical School, Sichuan University, Chengdu, P.R.China

²Department of Biopharmaceutics, Key Laboratory of Drug Targeting and Drug Delivery Systems, Ministry of Education, West China School of Pharmacy, Sichuan University, Chengdu, P.R. China

³College of Mathematics, Sichuan University, Chengdu, P.R. China

Cite this paper:
Xiaohong Li, Baozhan Huang, Fan Fei, Hai Niu and Wen Huang. In vitro Anti-angiogenic Effects of Tea Saponin and Tea Aglucone on Human Umbilical Vein Endothelial Cells. Journal of Food and Nutrition Research. 2015; 3(3):206-212. doi: 10.12691/jfnr-3-3-13

Abstract

Green tea is a popular beverage world-wide, especially in Asian countries. Its health benefits, derived from the Camellia sinensis leaves, have been studied over the years. However, few reports are available about the health effects of tea saponin (TS), an important component of Camellia sinensis leaves, and tea aglucone (TA). In this present study, we investigated the effect of TS and TA on the proliferation, migration, invasion and tube formation of human umbilical vein endothelial cells (HUVECs). TS inhibited the proliferation of HUVECs in a dose-dependent manner, with an IC50 of 7.5 ± 0.6 μM. Inconsistent with the well-reported mechanisms of apoptotic induction and cell cycle arrest by steroidal saponins, effects of TS on apoptosis and cell cycle progression in HUVECs were not detected. The autophagic vacuoles in the TS-treated HUVECs, observed with transmission electron microscopy, suggested the involvement of autophagic induction in the growth inhibition of HUVECs. When treated with TS, cell migration, invasion and tube formation potency of HUVECs were markedly suppressed. TA also suppressed the proliferation of HUVECs, with an IC50 of 25.3 ± 1.2 μM. In comparison with TS, TA inhibited the migration, invasion, and tube formation of HUVECs less effectively. Our data about the anti-angiogenic effects of TS and TA, presented for the first time, would provide a new insight into the health potential for green tea.

Keywords:
tea saponin tea aglucone anti-angiogenic effects human umbilical vein endothelial cells

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

Figures

References:

[1]	Serafini, M., DelRio, D., Yao, D.N., Bettuzzi, S., and Peluso, I., “Health benefits of tea”, in Herbal Medicine: Biomolecular and Clinical Aspects, 2nd Edn, Chapter 12, eds Benzie, I.F.F., and Wachtel-Galor, S., 2011.
[2]	Reygaert, W.C., “The antimicrobial possibilities of green tea,” Front Microbiol, 5. 434. Aug.2014.
[3]	Ferruzzi, M.G., “The influence of beverage composition on delivery of phenolic compounds from coffee and tea,” Physiol Behav, 100 (1). 33-41. Apr.2010.
[4]	Williamson, G., Dionisi, F., and Renouf, M., “Flavanols from green tea and phenolic acids from coffee: critical quantitative evaluation of the pharmacokinetic data in humans after consumption of single doses of beverages,” Mol Nutr Food Res, 55(6). 864-873. Jun.2011.
[5]	Matsui, Y., Kobayashi, K., Masuda, H., Kigoshi, H., Akao, M., Sakurai, H., and Kumagai, H., “Quantitative analysis of saponins in a tea-leaf extract and their antihypercholesterolemic activity,” Biosci Biotechnol Biochem, 73(7). 1513-1519. Jul.2009.
[6]	Katiyar, S.K., Afaq, F., Perez, A., and Mukhtar, H., “Green tea polyphenol (−)-epigallocatechin-3-gallate treatment of human skin inhibits ultraviolet radiation-induced oxidative stress,” Carcinogenesis, 22(2). 287-294. Feb.2001.
[7]	Jigisha, A., Nishant, R., Navin, K., and Pankaj, G., “Green tea: a magical herb with miraculous outcomes,” Int Res J Pharm, 3. 139-148. 2012.
[8]	Subramani, C., and Natesh, R.K., “Molecular mechanisms and biological implications of green tea polyphenol, (-)-epigallo catechin-3-gallate,” Int J Pharm Biosci Tech, 1. 54-63. 2013.
[9]	Folkman, J., “Angiogenesis in cancer, vascular, rheumatoid and other disease,” Nat Med, 1(1). 27-31. Jan.1995.
[10]	Carmeliet, P., and Jain, R.K., “Angiogenesis in cancer and other diseases,” Nature, 407(6801).249-257. Sep.2000.
[11]	Bergers, G., and Benjamin, L.E., “Tumorigenesis and the angiogenic switch,” Nat Rev Cancer, 3(6).401-410. Jun.2003.
[12]	Folkman, J., “Role of angiogenesis in tumor growth and metastasis,” Semin Oncol, 29 (6 Suppl 16).15-18. Dec.2002.
[13]	Zhang, S., Cao, Z., Tian, H., Shen, G., Ma, Y., Xie, H., Liu, Y., Zhao, C., Deng, S., Yang, Y., Zheng, R., Li, W., Zhang, N., Liu, S., Wang, W., Dai, L., Shi, S., Cheng, L., Pan, Y., Feng, S., Zhao, X., Deng, H., Yang, S., and Wei, Y., “SKLB1002, a novel potent inhibitor of VEGF receptor 2 signaling, inhibits angiogenesis and tumor growth in vivo,” Clin Cancer Res, 17(13). 4439-4450. Jul.2011.
[14]	Jaffe, E.A., Nachman, R.L., Becker, C.G., and Minick, C.R., “Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria,” J Clin Invest, 52(11). 2745-2756. Nov.1973.
[15]	Pang, X., Yi, Z., Zhang, X., Sung, B., Qu, W., Lian, X., Aggarwal, B.B., and Liu, M., “Acetyl-11-ketob-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis,” Cancer Res, 69(14). 5893-5900. Jul.2009.
[16]	Polverini, P.J., “The pathophysiology of angiogenesis,” Crit Rev Oral Biol Med, 6(3). 230-247.1995.
[17]	Bischoff, J., “Cell adhesion and angiogenesis,” J Clin Invest, 99(3). 373-376. Feb.1997.
[18]	Kaufmann, W.K, and Kaufman, D.G., “Cell cycle control, DNA repair and initiation of carcinogenesis,” FASEB J, 7(12). 1188-1189. Sep.1993.
[19]	Kitanaka, C., and Kuchino, Y., “Caspase-independent programmed cell death with necrotic morphology,” Cell Death Differ, 6(6). 508-515. Jun.1999.
[20]	Kondo, Y., Kanzawa, T., Sawaya, R., and Kondo, S., “The role of autophagy in cancer development and response to therapy,” Nat Rev Cancer, 5(9). 726-734. Sep.2005.
[21]	Lum, J.J., DeBerardinis, R.J., and Thompson, C.B., “Autophagy in metazoans: cell survival in the land of plenty,” Nat Rev Mol Cell Biol, 6(6). 439-448. Jun.2005.
[22]	Siddiqui, I.A., Asim, M., Hafeez, B.B., Adhami, V.M., Tarapore, R.S., and Mukhtar, H., “Green tea polyphenol EGCG blunts androgen receptor function in prostate cancer,” FASEB J, 25(4). 1198-1207. Apr. 2011.
[23]	Bettuzzi, S., Brausi, M., Rizzi, F., Castagnetti, G., Peracchia, G., and Corti, A., “Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study,” Cancer Res, 66(2).1234-1240. Jan.2006.
[24]	Sagesaka, Y.M., Uemura, T., Watanabe, N., Sakata, K., and Uzawa, J., “A new glucuronide saponin from tea leaves (Camellia sinensis var. sinensis),” Biosci Biotechnol Biochem, 58(11). 2036-2040. Nov.1994.
[25]	Murakami, T., Nakamura, J., Kageura, T., Matsuda, H., and Yoshikawa, M., “Bioactive saponins and glycosides. XVII. Inhibitory effect on gastric emptying and accelerating effect on gastrointestinal transit of tea saponins: structures of assamsaponins F, G, H, I, and J from the seeds and leaves of the tea plant,” Chem Pharm Bull, 48(11).1720-1725. Nov.2000.
[26]	Kobayashi, K., Teruya, T., Suenaga, K., Matsui, Y., Masuda, H., and Kigoshi, H., “Isotheasaponins B1-B3 from Camellia sinensis var. sinensis tea leaves,” Phytochemistry, 67(13). 1385-1389. Jul.2006.
[27]	Morikawa, T., Nakamura, S., Kato, Y., Muraoka, O., Matsuda, H., and Yoshikawa, M., “Bioactive Saponins and Glycosides. XXVIII. New Triterpene Saponins, Foliatheasaponins I, II, III, IV, and V, from Tencha (the Leaves of Camellia sinensis),” Chem Pharm Bull, 55(2). 293-298. Feb.2007.
[28]	Sagesaka, Y.M., Uemura, T., Suzuki, Y., Sugiura, T., Yoshida, M., Yamaguchi, K., and Kyuki, K., “Antimicrobial and anti-inflammatory actions of tea-leaf saponin,”Yakugaku Zasshi (in Japanese), 116(3). 238-243. Mar.1996.
[29]	Akagi, M., Fukuishi, N., Kan, T., Sagesaka, Y.M., and Akagi, R., “Anti-allergic effect of tea-leaf saponin (TLS) from tea leaves (Camellia sinensis var. sinensis),” Biol Pharm Bull, 20(5), 565-567. May.1997.
[30]	Matsui, Y., Kobayashi, K., Masuda, H., Kigoshi, H., Akao, M., Sakurai, H., and Kumagai, H., “Quantitative analysis of saponins in a tea-leaf extract and their antihypercholesterolemic activity,” Biosci Biotechnol Biochem, 73(7). 1513-1519. Jul.2009.
[31]	Xia, Y., Song, X., Li, D., Ye, T., Xu, Y., Lin, H., Meng, N., Li, G., Deng, S., Zhang, S., Liu, L., Zhu, Y., Zeng, J., Lei, Q., Pan, Y., Wei, Y., Zhao, Y., and Yu, L., “YLT192, a novel, orally active bioavailable inhibitor of VEGFR2 signaling with potent antiangiogenic activity and antitumor efficacy in preclinical models,” Sci Rep, 4. 6031. Aug.2014.
[32]	Muslim, N.S., Nassar, Z.D., Aisha, A.F., Shafaei, A., Idris, N., Majid, A.M., and Ismail, Z., “Antiangiogenesis and antioxidant activity of ethanol extracts of Pithecellobium jiringa,” BMC Complement Altern Med, 12. 210. Nov.2012.
[33]	Okawara, M., Tokudome, Y., Todo, H., Sugibayashi, K., and Hashimoto, F., “Effect of β-cyclodextrin derivatives on the diosgenin absorption in Caco-2 cell monolayer and rats,” Biol Pharm Bull, 37(1).54-59. 2014.
[34]	Okawara, M., Tokudome, Y., Todo, H., Sugibayashi, K., and Hashimoto, F., “Enhancement of diosgenin distribution in the skin by cyclodextrin complexation following oral administration,” Biol Pharm Bull, 36(1). 36-40. 2013.
[35]	Liu, M.J., Wang, Z., Ju, Y., Wong, R.N., and Wu, Q.Y., “DiosTA induces cell cycle arrest and apoptosis in human leukemia K562 cells with the disruption of Ca2+ homeostasis,” Cancer Chemother Pharmacol, 55(1). 79-90. Jan.2005.
[36]	Raju, J., Patlolla, J.M., Swamy, M.V., and Rao, C.V., “Diosgenin, a steroid saponin of Trigonella foenum graecum (Fenugreek), inhibits azoxymethane-induced aberrant crypt foci formation in F344 rats and induces apoptosis in HT-29 human colon cancer cells,” Cancer Epidemiol Biomarkers Prev, 13(8).1392-1398. Aug.2004.
[37]	Leger, D.Y., Liagre, B., Cardot, P.J., Beneytout, J.L., and Battu, S., “DiosTA dosedependent apoptosis and differentiation induction in human erythroleukemia cell line and sedimentation field-flow fractionation monitoring,” Anal Biochem, 335(2). 267-278. Dec.2004.
[38]	Yang, Z., and Klionsky, D.J., “An overview of the molecular mechanism of autophagy,” Curr Top Microbiol Immunol, 335.1-32. 2009.
[39]	Mizushima, N., “Autophagy: process and function,” Genes Dev, 21(22). 2861-2873. Nov.2007.
[40]	Tong, Q., Zhao, Q., Qing, Y., Hu, X., Jiang, L., Wu, X., “Deltonin inhibits angiogenesis by regulating VEGFR2 and subsequent signaling pathways in endothelial cells,” Steroids, 96C. 30-36. Dec.2014.
[41]	Kim, J.D., Chaudhary, N., Seo, H.J., Kim, M.Y., Shin, T.S, “Theasaponin E₁ as an effective ingredient for anti-angiogenesis and anti-obesity effects,” Biosci Biotechnol Biochem, 78(2). 279-287. 2014.